Combo pill superior to ibuprofen for migraine

	Tweet

A combination of acetaminophen, aspirin and caffeine is more effective than ibuprofen for treating acute migraine pain, according to results of a head-to-head clinical trial.

The combination, which is sold over-the-counter as Excedrin Migraine, relieved pain more effectively and more quickly than ibuprofen, Dr. Jerome Goldstein of the San Francisco Headache Clinic and colleagues report in the March issue of Headache. Both drugs were more effective than placebo.

The findings support recent recommendations of the U.S. Headache Consortium and the German Migraine Headache Society, the researchers note. Both groups recommended acetaminophen, aspirin plus caffeine as first-line treatment for mild-to-moderate migraine and tension-type headache.

Fifty-seven percent of migraineurs treat themselves with other-the-counter medications, Goldstein and his team note. To date, no study has compared such medications for migraine treatment.

To investigate, the researchers randomized 1,555 migraineurs to a single dose of two tablets each containing 250 mg acetaminophen, 250 mg aspirin and 65 mg caffeine; 200 mg ibuprofen; or placebo.

Meaningful pain relief occurred at 128.4 minutes post-dose with acetaminophen/aspirin/caffeine; 147.9 minutes with ibuprofen; and 167.1 with placebo.

Two, three and four hours post-dose, pain relief scores were higher with the triple therapy than with ibuprofen and placebo.

The combination of acetaminophen/aspirin/caffeine outperformed placebo for pain relief beginning at 45 minutes post-dose, and remained significantly more effective throughout the study. Ibuprofen pain relief scores exceeded placebo beginning at 90 minutes post-dose.

Significantly more patients in the ibuprofen and placebo groups required rescue medication at two hours post-dose compared to the other group. Adverse events with both drugs were mild, and included nervousness and nausea more frequently with acetaminophen/aspirin/caffeine and sleepiness more frequently with ibuprofen.

“These findings have important implications for medical professionals and their patients,” Goldstein and his colleagues write. “For the first time, rigorous data show that OTC (over-the-counter) medications are safe and effective in an unrestricted migraine patient population, and that there are significant differences between the two approved OTC migraine therapies.”

SOURCE: Headache March 2006. 

RELATED STORIES:
Naturopathic Medicine Successfully Reverses Migraines   Headaches during menopause can degenerate to find out what you can do   Migraine and Increased Risk of Cardiovascular Disease: Migraine Frequency Plays a Role   Migraine patients may have genetic abnormalities   Teenagers from Low Income Families at Greater Risk of Migraine   Treatment to Prevent Migraines Boosts Work Productivity   Scientists identify protein that may promote migraines   Severe migraines do not need narcotic pain drugs   A primer on migraine headaches   Biologists link locust comas with human migraine   Migraine: Aspirin and an antiemetic is a reasonable option   Does Air Pollution or Weather Trigger Headaches?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]